Bumper Offer - Urjas oil Just @ Rs. 1
CTD T AM 6.25/40/5 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when CTD T AM 6.25/40/5 Tablet (10) is used -
Severe
Moderate
Mild
Common
Is the use of CTD T AM 6.25/40/5 Tablet (10) safe for pregnant women?
Pregnant women may get mild side effects from CTD T AM Tablet.
Is the use of CTD T AM 6.25/40/5 Tablet (10) safe during breastfeeding?
Side effects of CTD T AM Tablet on breastfeeding women are very mild.
What is the effect of CTD T AM 6.25/40/5 Tablet (10) on the Kidneys?
CTD T AM Tablet may have mild side effects on the kidneys.
What is the effect of CTD T AM 6.25/40/5 Tablet (10) on the Liver?
CTD T AM Tablet is rarely harmful for the liver.
What is the effect of CTD T AM 6.25/40/5 Tablet (10) on the Heart?
CTD T AM Tablet has very mild side effects on the heart.
CTD T AM 6.25/40/5 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take CTD T AM 6.25/40/5 Tablet (10) unless your doctor advises you to do so -
Is this CTD T AM 6.25/40/5 Tablet (10) habit forming or addictive?
CTD T AM 6.25/40/5 Tablet (10) does not cause addiction.
Interaction between Food and CTD T AM 6.25/40/5 Tablet (10)
Eating certain foods may increase the time it takes CTD T AM 6.25/40/5 Tablet (10) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and CTD T AM 6.25/40/5 Tablet (10)
Taking CTD T AM 6.25/40/5 Tablet (10) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
